Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China
Background Since 2008, Fujian province provided measles-rubella (MR) vaccine at 8 months followed by measles-mumps-rubella (MMR) vaccine at 18 months a one-dose mumps-containing-vaccine (MuCV) schedule. Several mumps outbreaks have occurred recently in Fujian. Serological surveillance can assess pop...
| Հիմնական հեղինակներ: | , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Taylor & Francis Group
2022-11-01
|
| Շարք: | Human Vaccines & Immunotherapeutics |
| Խորագրեր: | |
| Առցանց հասանելիություն: | http://dx.doi.org/10.1080/21645515.2022.2096375 |